Fas (CD95, APO-1) Antigen Expression and Function in Murine Mast Cells

Journal of Immunology

Volumn 159, Issue 8, 1997, Pages 4006-4014

  Hartmann, Karin ^a,c   Wagelie Steffen, Amy L ^a   Von Stebut, Esther ^b   Metcalfe, Dean D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HUMBOLDT UNIVERSITY   (Germany)

^c Deutsche Forschungsgemeinschaft   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; CROSS LINKING REAGENT; DACTINOMYCIN; FAS ANTIGEN; FAS LIGAND; FASL PROTEIN, MOUSE; IMMUNOGLOBULIN E RECEPTOR; LIGAND; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL LINE; CELL SURVIVAL; COCULTURE; CYTOTOXIC T LYMPHOCYTE; HYBRIDOMA; IMMUNOLOGY; MAST CELL; METABOLISM; MOUSE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; PHYSIOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; CELL LINE; CELL SURVIVAL; CHROMIUM RADIOISOTOPES; COCULTURE TECHNIQUES; CROSS-LINKING REAGENTS; DACTINOMYCIN; FAS LIGAND PROTEIN; HYBRIDOMAS; LIGANDS; MAST CELLS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED MRL LPR; RECEPTORS, IGE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031572437     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Galli, S. J., and B. K. Wershil. 1996. The two faces of the mast cell. Nature 381:21.
2. Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381:77.
3. Echtenacher, B., D. N. Männel, and L. Hültner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381:75.
4. Kirshenbaum, A. S., J. P. Goff, S. C. Dreskin, A.-M. Irani, L. B. Schwartz, and D. D. Metcalfe. 1989. IL-3-dependent growth of basophil-like cells and mastlike cells from human bone marrow. J. Immunol. 142:2424.
5. Bressler, R. B., H. L. Thompson, J. M. Keffer, and D. D. Metcalfe. 1989. Inhibition of the growth of IL-3-dependent mast cells from murine bone marrow by recombinant granulocyte macrophage-colony-stimulating factor. J. Immunol. 143:135.
6. + bone marrow progenitor cells. J. Immunol 146:1410.
7. Tsai, M., T. Takeishi, H. Thompson, K. E. Langley, K. M. Zsebo, D. D. Metcalfe, E. N. Geissler, and S. J. Galli. 1991. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc. Natl. Acad. Sci. USA 88:6382.
8. + pluripotent progenitor cells. J. Immunol. 148:772.
9. Mekori, Y. A., C. K. Oh, and D. D. Metcalfe. 1993. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3: prevention of apoptosis by c-kit ligand. J. Immunol. 151:3775.
10. Yee, N. S., I. Pack, and P. Besmer. 1994. Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of while spotting and steel mutant mice. J. Exp. Med. 179:1777.
11. Mekori, Y. A., and D. D. Metcalfe. 1994. Transforming growth factor-β prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation. J. Immunol. 153:2194.
12. Iemura, A., M. Tsai, A. Ando, B. K. Wershil, and S. J. Galli. 1994. The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am. J. Pathol. 144:321.
13. Oehm, A., I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B. C. Trauth, H. Ponstingl, and P. H. Krammer. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen. J. Biol. Chem. 267:10709.
14. Watanabe-Fukunaga, R., C. I. Brannan, N. Itoh, S. Yonehara, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148:1274.
15. Trauth, B. C., C. Klas, A. M. J. Peters, S. Matzku, P. Möller, W. Falk, K.-M. Debatin, and P. H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301.
16. Iwai, K., T. Miyawaki, T. Takizawa, A. Konno, K. Ohta, A. Yachie, H. Seki, and N. Taniguchi. 1994. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84:1201.
17. Richardson, B. C., N. D. Lalwani, K. J. Johnson, and R. M. Marks. 1994. Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur. J. Immunol. 24:2640.
18. Weller, M., K. Frei, P. Groscurth, P. H. Krammer, Y. Yonekawa, and A. Fontana. 1994. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells: induction and modulation of sensitivity by cytokines. J. Clin. Invest. 94:954.
19. Garrone, P., E.-M. Neidhardt, E. Garcia, L. Galibert, C. van Kooten, and J. Banchereau. 1995. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 182:1265.
20. Schattner, E. J., K. B. Elkon, D.-H. Yoo, J. Tumang, P. H. Krammer, M. K. Crow, and S. M. Friedman. 1995. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 182:1557.
21. Matsue, H., H. Kobayashi, T. Hosokawa, T. Akitaya, and A. Ohkawara. 1995. Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN-γ-treated cultured keratinocytes. Arch. Dermatol. Res. 287:315.
22. Matsumoto, K., R. P. Schleimer, H. Saito, Y. Iikura, and B. S. Bochner. 1995. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 86:1437.
23. Hata, H., H. Matsuzaki, M. Takeya, M. Yoshida, T. Sonoki, A. Nagasaki, N. Kuribayashi, F. Kawano, and K. Takatsuki. 1995. Expression of Fas/Apo-1 (CD95) and apoptosis in tumor cells from patients with plasma cell disorders. Blood 86:1939.
24. Owen-Schaub, L. B., S. Yonehara, W. L. Crump III, and E. A. Grimm. 1992. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140:197.
25. Klas, C., K.-M. Debatin, R. R. Jonker, and P. H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:625.
26. Alderson, M. R., R. J. Armitage, E. Maraskovsky, T. W. Tough, E. Roux, K. Schooley, F. Ramsdell, and D. H. Lynch. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178:2231.
27. Dhein, J., H. Walczak, C. Bäumler, K.-M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438.
28. Takenaka, K., K. Nagafuji, M. Harada, S.-i. Mizuno, T. Miyamoto, S. Makino, H. Gondo, T. Okamura, and Y. Niho. 1996. In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95). Blood 88:2871.
29. Debatin, K.-M., D. Süss, and P. H. Krammer. 1994. Differential expression of APO-1 on human thymocytes: implications for negative selection? Eur. J. Immunol. 24:753.
30. Oshimi, Y., S. Oda, Y. Honda, S. Nagata, and S. Miyazaki. 1996. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J. Immunol. 157:2909.
31. Krammer, P. H., J. Dhein, H. Walczak, I. Behrmann, S. Mariani, B. Matiba, M. Path, P. T. Daniel, E. Knipping, M. O. Westendorp, K. Stricker, C. Bäumler, S. Hellbardt, M. Germer, M. E. Peter, and K.-M. Debatin. 1994. The role of APO-1-mediated apoptosis in the immune system. Immunol. Rev. 142:175.
32. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189.
33. Hahne, M., D. Rimoldi, M. Schröter, P. Romero, M. Schreier, L. E. French, P. Schneider, T. Bornand, A. Fontana, D. Lienard, J.-C. Cerottini, and J. Tschopp. 1996. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 274:1363.
34. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
35. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
36. Arora, N., K.-U. Min, J. J. Costa, J. S. Rhim, and D. D. Metcalfe. 1993. Immortalization of mouse bone marrow-derived mast cells with Ad12-SV40 virus. Int. Arch. Allergy Appl. Immunol. 100:319.
37. Tsai, M., J. Hunt, J. P. Arm, C. London, M. Gurish, and S. J. Galli. 1996. The C1.MC/C57.1(C57) mouse mast cell line is of BALB/c origin and is tumorigenic in BALB/c mice. FASEB J. 10:A1218.
38. Razin, E., J. N. Ihle, D. Seldin, J.-M. Mencia-Huerta, H. R. Katz, P. A. Leblanc, A. Hein, J. P. Caulfield, K. F. Austen, and R. L. Stevens. 1984. Interleukin 3: a differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J. Immunol. 132:1479.
39. Yurt, R. W., R. W. Leid, Jr., J. Spragg, and K. F. Austen. 1977. Immunologic release of heparin from purified rat peritoneal mast cells. J. Immunol. 118:1201.
40. Darzynkiewicz, Z., S. Bruno, G. Del Bino, W. Gorczyca, M. A. Hotz, P. Lassota, and F. Traganos. 1992. Features of apoptotic cells measured by flow cytometry. Cytometry 13:795.
41. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493.
42. Darzynkiewicz, Z., X. Li, and J. Gong. 1994. Assays of cell viability: discrimination of cells dying by apoptosis. Methods Cell Biol. 41:15.
43. Boehme, S. A., and M. J. Lenardo. 1993. Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur. J. Immunol. 23:1552.
44. Fisher, G. H., F. J. Rosenberg, S. E. Straus, J. K. Dale, L. A. Middleton, A. Y. Lin, W. Strober, M. J. Lenardo, and J. M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935.
45. Ni, R., Y. Tomita, K. Matsuda, A. Ichihara, K. Ishimura, J. Ogasawara, and S. Nagata. 1994. Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp. Cell Res. 215:332.
46. Esser, P., K. Heimann, H. Abts, A. Fontana, and M. Weller. 1995. CD95 (Fas/ APO-1) antibody-mediated apoptosis of human retinal pigment epithelial cells. Biochem. Biophys. Res. Commun. 213:1026.
47. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
48. Sarin, A., M. S. Williams, M. A. Alexander-Miller, J. A. Berzofsky, C. M. Zacharchuk, and P. A. Henkart. 1997. Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity 6:209.
49. Garriga, M. M., M. M. Friedman, and D. D. Metcalfe. 1988. A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders. J. Allergy Clin. Immunol. 82:425.
50. Galli, S. J. 1990. New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab. Invest. 62:5.
51. Hughes, D. P. M., and I. N. Crispe. 1995. A naturally occurring soluble isoform of murine Fas generated by alternative splicing. J. Exp. Med. 182:1395.
52. Agis, H., W. Füreder, H. C. Bankl, M. Kundi, W. R. Sperr, M. Willheim, G. Boltz-Nitulescu, J. H. Butterneid, K. Kishi, K. Lechner, and P. Valent. 1996. Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology 87:535.
53. Itoh, N., Y. Tsujimoto, and S. Nagata. 1993. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151:621.
54. Mapara, M. Y., R. Bargou, C. Zugck, H. Döhner, F. Ustaoglu, R. R. Jonker, P. H. Krammer, and B. Dörken. 1993. APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur. J. Immunol. 23:702.
55. Park, J. R., I. D. Bernstein, and D. M. Hockenbery. 1995. Primitive human hematopoietic precursors express Bcl-x but not Bcl-2. Blood 86:868.
56. McGahon, A. J., W. K. Nishioka, S. J. Martin, A. Mahboubi, T. G. Cotter, and D. R. Green. 1995. Regulation of the Fas apoptotic cell death pathway by Abl. J. Biol. Chem. 270:22625.
57. Deiss, L. P., H. Galinka, H. Berissi, O. Cohen, and A. Kimchi. 1996. Cathepsin D protease mediates programmed cell death induced by interferon-γ, Fas/APO-1 and TNF-α. EMBO J. 15:3861.
58. 2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271:521.
59. Finotto, S., Y. A. Mekori, and D. D. Metcalfe. 1997. Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells. J. Clin. Invest. 99:1721.